Deloitte Legal (as formerly Laga) assisted CryoTherapeutics with EUR 7M Series B financing round
Taking on your challenges
16 July 2019
Deloitte Legal assisted medtech company CryoTherapeutics in its closing of a Series B financing round of EUR 7 million. In the process of the transaction, our law firm assisted CryoTherapeutics in all corporate and tax aspects relating to the relocation of the R&D activities of the company and the subsequent investment by existing shareholders and Belgian institutional investors. The funds will help the company with its clinical trials programme and the setup of operations at its new facility in Awans (Liège).
The Belgian public investor Noshaq (formerly Meusinvest), the Walloon region, as well as existing investors Peppermint Venture Partners, Creathor Ventures and Getz Brothers participated in this financing.
Established in Germany in 2009, CryoTherapeutics specialises in the development, clinical benefit demonstration and early-stage commercialisation of cryotherapy systems used to treat coronary artery disease.
The Deloitte Legal team of lawyers was composed of Anne Tilleux and William Hollander from the Corporate and M&A practice, with Eric von Frenckell and Justine Smeets covering the Tax aspects of the transaction.